Niacin Extended-Release is used to treat high cholesterol and triglycerides

07:16, Tue, Jun 16, 2026 Updated: 07:22, Tue, Jun 16, 2026

Medicines of different shapes and colors are on the right. medical equipment. health concept.

Medicines of different shapes and colours (stock image) (Image: Getty)

The US Food and Drug Administration (FDA) on Friday issued a report that 2,961 bottles of a 1,000-milligram Vitamin B supplement used to lower high cholesterol and triglycerides had been recalled.

The FDA listed the reason for recall of the Niacin Extended-Release brand as: Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.

Get the latest news from around the world and more Invalid email

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. Read our Privacy Policy

This could mean that tests on stored inventory within a year after manufacture showed the drug was releasing less active ingredient than intended at the 24-hour mark.

The FDA said five lots of the drug show an expiration date of 1/31/2027, these being: GS065128, GS065844, GS066695, GS067432, GS067993.

You can identify whether your prescription is affected by using the following details:

  • GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP
  • 1,000 MG
  • 90 tablets
  • Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274
  • Packaged by GSMS Incorporated, Camarillo, CA 93012

The report says the recalling company, Golden State Medical Supply Inc. of Camarillo, CA, voluntarily recalled the drug.

The FDA has given this event a Class II risk level, indicating "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."

It is advisable to contact your prescribing doctor or dispensing pharmacist right away for a replacement, and before stopping consumption of the drug.